MXPA02002043A - Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive. - Google Patents
Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive.Info
- Publication number
- MXPA02002043A MXPA02002043A MXPA02002043A MXPA02002043A MXPA02002043A MX PA02002043 A MXPA02002043 A MX PA02002043A MX PA02002043 A MXPA02002043 A MX PA02002043A MX PA02002043 A MXPA02002043 A MX PA02002043A MX PA02002043 A MXPA02002043 A MX PA02002043A
- Authority
- MX
- Mexico
- Prior art keywords
- drospirenone
- ethinylestradiol
- contraceptive
- pharmaceutical combination
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24095399P | 1999-08-31 | 1999-08-31 | |
| EP99202826 | 1999-08-31 | ||
| PCT/IB2000/001213 WO2001015701A1 (en) | 1999-08-31 | 2000-08-31 | Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA02002043A true MXPA02002043A (en) | 2003-08-20 |
Family
ID=26153358
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA02002043A MXPA02002043A (en) | 1999-08-31 | 2000-08-31 | Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive. |
Country Status (11)
| Country | Link |
|---|---|
| CN (1) | CN1223350C (en) |
| BG (2) | BG109749A (en) |
| CA (1) | CA2382426C (en) |
| EE (1) | EE05317B1 (en) |
| HR (1) | HRP20020258B1 (en) |
| IL (2) | IL197396A (en) |
| MX (1) | MXPA02002043A (en) |
| NO (3) | NO327588B3 (en) |
| RU (4) | RU2269342C2 (en) |
| SK (1) | SK287634B6 (en) |
| UA (1) | UA81387C2 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1625849A1 (en) * | 2004-08-09 | 2006-02-15 | Liconsa, Liberacion Controlada de Sustancias Activas, S.A. | Pharmaceutical composition comprising drospirenone and ethynylestradiol |
| CN101489563A (en) * | 2006-07-06 | 2009-07-22 | 拜耳先灵医药股份有限公司 | Pharmaceutical preparations for contraception and for preventing the risk of congenital malformations |
| US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| CA2856520C (en) | 2011-11-23 | 2021-04-06 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| RU2618471C2 (en) * | 2012-12-03 | 2017-05-03 | Закрытое Акционерное Общество "Вертекс" | Oral pharmaceutical composition of diuretics and ace inhibitor in micronized form, drug and its application |
| US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| AR100562A1 (en) | 2014-05-22 | 2016-10-12 | Therapeuticsmd Inc | PHARMACEUTICAL COMPOSITION OF ESTRADIOL AND PROGESTERONE FOR HORMONAL REPLACEMENT THERAPY |
| CN108606963B (en) * | 2017-12-27 | 2021-05-18 | 上海长海医院 | Compound contraceptive patch containing drospirenone and estrogen, preparation method and application |
| CN111529482A (en) * | 2020-05-20 | 2020-08-14 | 祝培 | Testosterone undecanoate sustained-release implant and application thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2652761C2 (en) * | 1976-11-16 | 1985-11-21 | Schering AG, 1000 Berlin und 4709 Bergkamen | 15,16-methylene-spirolactones, processes for their preparation and pharmaceuticals containing them |
| DE4344462C2 (en) * | 1993-12-22 | 1996-02-01 | Schering Ag | Composition for contraception |
| DE4411585A1 (en) * | 1994-03-30 | 1995-10-05 | Schering Ag | Combined pharmaceutical preparation for hormonal contraception |
| AU726091B2 (en) * | 1996-07-26 | 2000-11-02 | Wyeth | Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen |
-
2000
- 2000-08-31 HR HR20020258A patent/HRP20020258B1/en not_active IP Right Cessation
- 2000-08-31 SK SK257-2002A patent/SK287634B6/en not_active IP Right Cessation
- 2000-08-31 MX MXPA02002043A patent/MXPA02002043A/en active IP Right Grant
- 2000-08-31 EE EEP200900049A patent/EE05317B1/en not_active IP Right Cessation
- 2000-08-31 UA UA2002032519A patent/UA81387C2/en unknown
- 2000-08-31 CN CNB008150540A patent/CN1223350C/en not_active Expired - Lifetime
- 2000-08-31 RU RU2002107987/15K patent/RU2269342C2/en not_active IP Right Cessation
- 2000-08-31 CA CA002382426A patent/CA2382426C/en not_active Expired - Lifetime
- 2000-08-31 RU RU2002107987/15A patent/RU2269342C9/en not_active IP Right Cessation
-
2002
- 2002-03-20 BG BG109749A patent/BG109749A/en unknown
- 2002-03-20 BG BG106533A patent/BG65204B1/en unknown
-
2005
- 2005-10-14 RU RU2005131868/15A patent/RU2396082C2/en active
-
2008
- 2008-09-08 NO NO20083854A patent/NO327588B3/en not_active IP Right Cessation
-
2009
- 2009-03-04 IL IL197396A patent/IL197396A/en active IP Right Grant
- 2009-05-07 NO NO20091809A patent/NO20091809L/en not_active Application Discontinuation
- 2009-08-19 IL IL200482A patent/IL200482A0/en unknown
-
2010
- 2010-02-26 NO NO2010004C patent/NO2010004I1/en unknown
- 2010-04-14 RU RU2010114825/15A patent/RU2482853C2/en active
Also Published As
| Publication number | Publication date |
|---|---|
| BG65204B1 (en) | 2007-07-31 |
| RU2482853C2 (en) | 2013-05-27 |
| NO20083854L (en) | 2002-04-26 |
| RU2449796C9 (en) | 2007-10-27 |
| IL197396A (en) | 2010-04-29 |
| HRP20020258A2 (en) | 2005-02-28 |
| RU2449796C2 (en) | 2006-02-10 |
| NO327588B1 (en) | 2009-08-31 |
| SK287634B6 (en) | 2011-04-05 |
| RU2010114825A (en) | 2011-10-20 |
| IL200482A0 (en) | 2011-07-31 |
| EE200900049A (en) | 2009-10-15 |
| NO2010004I1 (en) | 2010-03-22 |
| RU2269342C2 (en) | 2006-02-10 |
| BG109749A (en) | 2008-06-30 |
| CA2382426C (en) | 2006-02-28 |
| RU2005131868A (en) | 2007-04-20 |
| CA2382426A1 (en) | 2001-03-08 |
| SK2572002A3 (en) | 2002-11-06 |
| CN1407895A (en) | 2003-04-02 |
| EE05317B1 (en) | 2010-08-16 |
| NO20091809L (en) | 2002-04-26 |
| HRP20020258B1 (en) | 2007-05-31 |
| NO327588B3 (en) | 2011-05-16 |
| BG106533A (en) | 2002-10-31 |
| RU2396082C2 (en) | 2010-08-10 |
| CN1223350C (en) | 2005-10-19 |
| RU2269342C9 (en) | 2007-10-27 |
| UA81387C2 (en) | 2008-01-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0202500A2 (en) | Use of a pharmaceutical combination of ethinylestradiol and drospirenone for producing pharmaceutical compositions having contraceptive activity | |
| IL200482A0 (en) | Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive | |
| PL345955A1 (en) | PHARMACEUTICAL COMPOSITIONS AND USES FOR ANDROST-5-ENE-3β,17β-DIOL | |
| IL145983A0 (en) | Pharmaceutical composition for dermal use, comprising a corticosteroid and a vitamin d or an analogue thereof | |
| ZA9810136B (en) | Anti-estrogen plus progestin containing oral contraceptives. | |
| IL142523A0 (en) | Drug delivery device, especially for the delivery of progestins and estrogens | |
| IL146230A0 (en) | 3α-HYDROXY-3β-METHOXYMETHYL-SUBSTITUTED STEROIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
| HUP0400646A3 (en) | Steroid hormone-compositions and processes for their preparation | |
| IL154521A0 (en) | Contraception process and administration form for the same | |
| AP9801173A0 (en) | Rapidly releasing and taste-making pharmaceutical dosage | |
| IL161105A0 (en) | Estrogen/gestagen combination preparation and application thereof | |
| HUP0301333A3 (en) | Pharmaceutical superdisintegrant, process for its preparation and its use | |
| AP2004003046A0 (en) | Dosage regimen and pharmaceutical composition for emergency contraception. | |
| PL334518A1 (en) | Derivatives of 16-hydroxy-11-(phenyl-substituted) -estra-4,9-diene- | |
| ZA200108001B (en) | Processes for making pharmaceutical oral ECB formulations and compositions. | |
| CZ2006533A3 (en) | Amorphous ritonavir, methods for its preparation, its use, and a pharmaceutical composition comprising it | |
| EP1226154A4 (en) | Estradiol conjugates and uses thereof | |
| EP1236452A4 (en) | Condom | |
| AP2002002475A0 (en) | Hormonal composition based on a progesterone and an oestrogen and use thereof | |
| MXPA01011296A (en) | Contraceptive compositions containing indoline derivatives and progestational agents. | |
| ZA200201668B (en) | Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive. | |
| HUP0300128A3 (en) | Male contraceptive composition comprising norethisterone and its use | |
| HU0900070D0 (en) | Use of a pharmaceutical combination of ethinylestradiol and drospirenone as a contraceptive | |
| AU7034800A (en) | Pelvic condom | |
| HU0900069D0 (en) | Use of a pharmaceutical combination of ethinylestradiol and prospirenone as a contraceptive |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| GD | Licence granted | ||
| HC | Change of company name or juridical status | ||
| HC | Change of company name or juridical status |